Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Aug 22, 2016, 09:30 ET Mezzion Pharma And NHLBI Initiate Enrollment In A Pivotal Phase 3 Clinical Trial Of Udenafil In Adolescents With Fontan Surgical Palliation - An Orphan Drug Indication

 Mezzion Pharma and the National Heart, Lung and Blood Institute (NHLBI) today announced the initiation of enrollment in a pivotal Phase 3...


Aug 22, 2016, 09:00 ET New Data Add To Understanding Of Repatha® (Evolocumab) In Multiple Patient Populations

Amgen (NASDAQ:AMGN) today announced that it will present 11 abstracts at the upcoming European Society of Cardiology (ESC) Congress 2016, being...


Aug 22, 2016, 08:00 ET Emmaus Life Sciences to Seek Marketing Approval for First New Sickle Cell Disease Treatment in Nearly 20 Years; Expects to Submit New Drug Application to FDA in September

 Culminating more than 20 years of research and development, Emmaus Life Sciences, Inc. today announced that it expects to submit a New Drug...


Aug 22, 2016, 08:00 ET BioPharmX Announces Final Phase 2a Trial Results Find BPX-01 Reduces Facial P. Acnes by More than 90% in Four Weeks

BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing products for the dermatology market, today released final...


Aug 22, 2016, 08:00 ET Janssen Announces 25 Presentations at Upcoming ESC Congress 2016, Including New Clinical and Real-World Research on XARELTO® and Latest Findings from REVISIT-US

Janssen Pharmaceuticals, Inc., today announced that 25 abstracts have been accepted for presentation by Janssen and its development partner, Bayer,...


Aug 22, 2016, 08:00 ET Lycera Announces Initiation of Phase 2 Clinical Trial of LYC-30937-EC in Patients with Ulcerative Colitis

 Lycera Corp., a privately held biopharmaceutical company developing breakthrough immune modulatory medicines, announced today the initiation...


Aug 22, 2016, 06:00 ET Lilly and AstraZeneca Receive FDA Fast Track Designation for AZD3293, an Investigational Treatment for Early Alzheimer's Disease

Eli Lilly and Company (NYSE: LLY) and AstraZeneca today announced they have received U.S. Food and Drug Administration (FDA) Fast Track designation...


Aug 19, 2016, 14:29 ET Revolutionary method to map the brain at single-neuron resolution successfully demonstrated

 Neuroscientists today publish in Neuron details of a revolutionary new way of mapping the brain at the resolution of individual neurons, which...


Aug 18, 2016, 14:39 ET FDA approves expanded indication for two transcatheter heart valves for patients at intermediate risk for death or complications associated with open-heart surgery

The U.S. Food and Drug Administration today approved an expanded indication for the Sapien XT and Sapien 3 transcatheter heart valves for patients...


Aug 18, 2016, 13:00 ET Benchmark Study Assessing Study Startup Published in Applied Clinical Trials

goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today the publication of the peer-reviewed article...


Aug 18, 2016, 09:00 ET Following Successful First Stage in Trial: Kadimastem Signed Agreement with Medical Device Company to Expand Joint Trials of Diabetes Therapy using Unique Encapsulation Device

Israeli biotechnology company Kadimastem (TASE: KDST) announced today that following success in the first stage of trials held under the agreement...


Aug 18, 2016, 08:30 ET REPATHA (evolocumabe): primeiro medicamento de uma classe inédita, para tratar colesterol alto de difícil controle, a ser aprovado pela Anvisa

Aprovado pela Anvisa em abril, RepathaTM (evolocumabe), acaba de ser lançado no mercado brasileiro. Trata-se do primeiro medicamento de uma...


Aug 18, 2016, 00:00 ET Avelas Biosciences Completes $20 Million Series C Financing

Avelas Biosciences, Inc., a clinical stage oncology-focused company dedicated to improving cancer patient care from diagnosis through treatment,...


Aug 17, 2016, 17:25 ET Juniper Pharmaceuticals Reports Results from Phase 2b Clinical Trial of COL-1077 Lidocaine Vaginal Gel in Gynecologic Procedure Pain

 Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) ("Juniper" or the "Company"), a women's health therapeutics company, today announced that a...


Aug 17, 2016, 15:25 ET Janssen Submits Application to U.S. FDA to Expand Indication for Daratumumab (DARZALEX®)

 Janssen Biotech, Inc. announced today a supplemental Biologics License Application (sBLA) for daratumumab (DARZALEX®) has been submitted...


Aug 17, 2016, 13:23 ET CollPlant Reports Positive Final Extended Clinical Trial Results with Vergenix™STR for Treatment of Tendinopathy

CollPlant Ltd. (TASE: CLPT), a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair...


Aug 17, 2016, 11:23 ET The Association for Molecular Pathology Establishes New Standard for Clinical Utility of Molecular Diagnostics for Inherited Diseases and Cancer

 The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, today...


Aug 17, 2016, 08:00 ET Evofem Announces First Patient Enrolled in a Clinical Trial to Determine the Effect and Duration of Amphora Gel on Vaginal pH

Evofem, a biotechnology company focused on the development and commercialization of women's health products, has announced that patient enrollment...


Aug 17, 2016, 08:00 ET Livongo for Diabetes Program Generates Positive Clinical, Financial Outcomes

Livongo Health, the leading consumer digital health company focused on improving care for chronic conditions, released new outcomes information...


Aug 17, 2016, 08:00 ET Audentes Therapeutics Announces First Patient Enrolled in the INCEPTUS Clinical Assessment Study of XLMTM

 Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for...